Loading clinical trials...
Loading clinical trials...
Phase 1, Single Ascending Dose Study of Subcutaneous BW-50218 in Healthy Participants
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Shanghai Argo Biopharmaceutical Co., Ltd.
NCT06852872 · Resistance Training, Healthy Participants Study
NCT07083414 · Oral Health Self-efficacy, Healthy Participants Study
NCT05339100 · Healthy Participants Study
CMAX Clinical Research Pty Ltd
Adelaide, South Australia
Linear Early Fhase Limited
Nedlands, Western Australia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions